A detailed history of Independent Investors Inc transactions in Amgen Inc stock. As of the latest transaction made, Independent Investors Inc holds 30,155 shares of AMGN stock, worth $8.24 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares
30,155
Previous 30,155 -0.0%
Holding current value
$8.24 Million
Previous $9.42 Million 3.13%
% of portfolio
1.98%
Previous 2.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$268.87 - $324.56 $103,783 - $125,280
-386 Reduced 1.26%
30,155 $8.57 Million
Q4 2022

Feb 02, 2023

SELL
$229.03 - $291.01 $121,385 - $154,235
-530 Reduced 1.71%
30,541 $8.02 Million
Q4 2021

Jan 31, 2022

SELL
$198.88 - $227.6 $29,832 - $34,140
-150 Reduced 0.48%
31,071 $6.99 Million
Q3 2021

Oct 28, 2021

SELL
$212.27 - $248.7 $42,454 - $49,740
-200 Reduced 0.64%
31,221 $6.64 Million
Q2 2021

Jul 28, 2021

BUY
$233.58 - $259.14 $46,716 - $51,828
200 Added 0.64%
31,421 $7.66 Million
Q4 2020

Jan 27, 2021

SELL
$216.38 - $257.67 $54,095 - $64,417
-250 Reduced 0.79%
31,221 $7.18 Million
Q4 2019

Jan 15, 2020

SELL
$189.21 - $243.2 $245,216 - $315,187
-1,296 Reduced 3.96%
31,471 $7.59 Million
Q3 2019

Oct 31, 2019

BUY
$174.11 - $208.62 $162,792 - $195,059
935 Added 2.94%
32,767 $6.34 Million
Q1 2019

May 01, 2019

SELL
$180.87 - $203.88 $18,810 - $21,203
-104 Reduced 0.33%
31,832 $6.05 Million
Q4 2018

Jan 14, 2019

SELL
$178.4 - $208.25 $160,560 - $187,425
-900 Reduced 2.74%
31,936 $6.22 Million
Q1 2018

May 04, 2018

SELL
$169.43 - $198.0 $62,689 - $73,260
-370 Reduced 1.11%
32,836 $5.6 Million
Q4 2017

Jan 30, 2018

SELL
$168.79 - $188.59 $75,786 - $84,676
-449 Reduced 1.33%
33,206 $5.77 Million
Q3 2017

Oct 24, 2017

BUY
$167.29 - $191.0 $5.63 Million - $6.43 Million
33,655
33,655 $6.27 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Independent Investors Inc Portfolio

Follow Independent Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Investors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Independent Investors Inc with notifications on news.